Crazy Shed After Starting Hair Treatment
    Finasteride/Dutasteride 7/19/2024

    From the encyclopedia
    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    RU58841 →

    a potent but unapproved and potentially problematic topical anti-androgen

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    At a glance
    In this question or advice post, the primary subjects mentioned are
    💊 Finasteride (oral) 2mg daily 4 months
    💧 RU58841 (topical) 4 months
    💧 Minoxidil (topical) 4 months
    💊 Dutasteride (oral) 0.5mg daily 1 month
    the tone is 😞 negative.

    Other terms

    The user experienced significant hair shedding after starting finasteride, RU58841, and topical minoxidil. They increased their finasteride dosage and added dutasteride, seeking advice on whether this reaction is normal and its duration.
    View this post in the Community →

    Similar Community Posts Join

    6 / 6 results

      community September - december with fin + oral & topical min + ru58841.

       165 upvotes 1 year ago
      The user experienced hair regrowth using finasteride, oral and topical minoxidil, and RU58841, despite initial shedding. They also transitioned from finasteride to dutasteride and addressed scalp issues with a folliculitis shampoo.

      community Topical dutasteride results 7 weeks progress

       8 upvotes 3 months ago
      A 22-year-old male is using topical dutasteride, minoxidil, tretinoin, and microneedling for hair loss, experiencing some side effects like mild ball pain and initial shedding but seeing progress in hair thickness. He plans to increase the dutasteride dose and has tried various treatments, including finasteride and RU58841, with differing side effects.

      community 20 year old male 2 years topical fin + min progress

       43 upvotes 3 months ago
      A 20-year-old male shares his 2-year progress using topical finasteride and minoxidil, with additional oral minoxidil, scalp massages, and microneedling. He reports no significant side effects, occasional hair shedding, and is considering switching to topical dutasteride and exploring RU58841.

    Related Research

    6 / 6 results
      Therapeutic Strategies for Treating Hair Loss

      research Therapeutic strategies for treating hair loss

      42 citations , March 2006 in “Drug Discovery Today: Therapeutic Strategies”
      This article discusses the need for rational strategies in developing hair loss drugs targeting specific events in hair follicle cycling, reporting no clinical findings but emphasizing the importance of understanding molecular controls.
      Hair Growth and Rejuvenation: An Overview

      research Hair growth and rejuvenation: An overview

      81 citations , June 2010 in “Journal of Dermatological Treatment”
      This review discusses recent advancements in hair rejuvenation strategies and assesses the potential of herbal drugs as safer alternatives, but reports no new clinical results.
      New Therapeutics in the Management of Androgenetic Alopecia

      research Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique

      March 2025 in “HAL (Le Centre pour la Communication Scientifique Directe)”
      This thesis investigates the underlying mechanisms and treatment options for androgenetic alopecia, highlighting the molecular roles of androgens and genetic predispositions, and evaluates current and emerging therapies, such as PROTACs and Janus Kinase inhibitors, to enhance patient management.
      Androgenetic Alopecia: An Update on Pathogenesis and Pharmacological Treatment

      research Androgenetic Alopecia: An Update on Pathogenesis and Pharmacological Treatment

      August 2025 in “Drug Design Development and Therapy”
      This review article examines current drugs for androgenetic alopecia, focusing on their mechanisms and clinical efficacy, noting that while finasteride and minoxidil are commonly approved treatments, new drugs targeting different pathogenic pathways have emerged, offering a broader understanding and reference for AGA treatment options.